Synthical logo
Your space
Activity icon
Favorites icon
Account icon
From chemRxiv
Mainz Institute for Theoretical Physics, Mansoura University, Johannes-Gutenberg Universität Mainz

Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the Ataxia telangiectasia and RAD3-related (ATR) kinase

The Ataxia telangiectasia and RAD3-related (ATR) kinase is a key regulator of the DNA replication stress responses and DNA-damage activated checkpoints. Several potent and selective ATR inhibitors are reported and four of them are currently in clinical trials in combination with radio- or chemotherapy. Based on the idea of degrading target proteins rather than inhibiting them, we designed, synthesized and biologically characterized a library of ATR-targeted proteolysis targeting chimera (PROTACs). Among the synthesized compounds, the lenalidomide-based PROTAC 42i (Abd110) was the most promising when tested in pancreatic cancer cells (MIA PaCa-2). It reduced ATR to 40 % of the levels in untreated cells. 42i (Abd110) selectively degraded ATR through the proteasome without affecting the associated kinases ATM and DNA-PKcs. 42i (Abd110) may be a promising candidate for further optimization and biological characterization in various cancer cells.
Upvote icon
Published on November 10, 2023
Copy BibTeX
Cross iconSummary
There is no AI-powered summary yet, because we do not have a budget to generate summaries for all articles.
1. Buy subscription
We will thank you for helping thousands of people to save their time at the top of the generated summary.
If you buy our subscription, you will be able to summarize multiple articles.
Pay $8
≈10 summaries
Pay $32
≈60 summaries
2. Share on socials
If this article gets to top-5 in trends, we'll summarize it for free.
Copy link